Related Experiment Video
Updated: Mar 1, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial
Shu-Huai Tsai1, Guangrong Lu2, Xin Xu1
1Department of Medical Physiology, Texas A&M University Health Science Center, Temple, TX, USA.
Insights
Pressure overload causes cardiac hypertrophy, leading to coronary microvascular dysfunction and ischemia. This is linked to oxidative stress, endothelin-1 (ET-1) vasoconstriction, and impaired nitric oxide (NO) function via elevated rho-kinase (ROCK) signaling.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Cardiac Pathophysiology
Background:
- Hypertensive cardiac hypertrophy impairs coronary flow reserve.
- The precise mechanisms affecting coronary flow regulation and vasomotor function are not fully understood.
Purpose of the Study:
- To investigate the impact of pressure overload-induced cardiac hypertrophy on coronary microvascular function and regulation in a mouse model.
- To explore the roles of endothelin-1 (ET-1), rho-kinases (ROCKs), and oxidative stress in this dysfunction.
Main Methods:
- Left ventricular hypertrophy was induced in mice via transverse aortic coarctation (TAC).
- Coronary microvascular function was assessed by measuring coronary arteriolar responses to acetylcholine (ACh) and ET-1.
- Myocardial and vascular oxidative stress markers and ROCK expression were evaluated.
Main Results:
- TAC mice exhibited increased heart-to-body weight ratio, reduced cardiac function, and impaired coronary blood flow response to isoproterenol.
- Coronary arterioles from TAC mice showed reversed nitric oxide (NO)-mediated dilation to ACh and augmented vasoconstriction to ET-1.
- Elevated myocardial ET-1, increased vascular ROCK expression, and heightened oxidative stress were observed in TAC mice.
Conclusions:
- Pressure overload-induced myocardial hypertrophy leads to cardiac and coronary microvascular dysfunction and ischemia.
- This dysfunction is potentially mediated by oxidative stress, enhanced ET-1 vasoconstriction, and compromised endothelial NO function.
- Elevated ROCK signaling plays a critical role in these pathological changes, suggesting it as a therapeutic target.
Aims:
Hypertensive cardiac hypertrophy is associated with reduced coronary flow reserve, but its impact on coronary flow regulation and vasomotor function remains incompletely understood and requires further investigation.
Methods And Results:
Left ventricular hypertrophy was induced in mice by transverse aortic coarctation (TAC) for 4 weeks. The left coronary artery blood velocity (LCABV) and myocardium lactate level were measured following the metabolic activation by isoproterenol. Septal coronary arterioles were isolated and pressurized for functional studies. In TAC mice, the heart-to-body weight ratio was increased by 45%, and cardiac fractional shortening and LCABV were decreased by 51 and 14%, respectively. The resting myocardial lactate level was 43% higher in TAC mice. Isoproterenol (5 µg/g, i.p.) increased heart rate by 20% in both groups of animals, but the corresponding increase in LCABV was not observed in TAC mice. The ventricular hypertrophy was associated with elevation of myocardial endothelin-1 (ET-1), increased vascular expression of rho-kinases (ROCKs), and increased superoxide production in the myocardium and vasculature. In coronary arterioles from TAC mice, the endothelial nitric oxide (NO)-mediated dilation to acetylcholine (ACh) was reversed to vasoconstriction and the vasoconstriction to ET-1 was augmented. Inhibition of ROCK by H-1152 alleviated oxidative stress and abolished enhanced vasoconstriction to ET-1. Both H-1152 and superoxide scavenger Tempol abolished coronary arteriolar constriction to ACh in a manner sensitive to NO synthase blocker NG-nitro-L-arginine methyl ester.
Conclusions:
Myocardial hypertrophy induced by pressure overload leads to cardiac and coronary microvascular dysfunction and ischaemia possibly due to oxidative stress, enhanced vasoconstriction to ET-1 and compromised endothelial NO function via elevated ROCK signalling.
Related Concept Videos
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Regulation of Angiogenesis and Blood Supply
Cardiomyopathy III: Hypertrophic Cardiomyopathy

